Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Aug 8, 2024
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Conversion
Series H Preferred Stock
2024-08-06−751,973→ 616,201 totalExercise: $0.20From: 2023-12-15→ Common Stock (7,519,730 underlying) - Conversion
Common Stock
2024-08-06$0.20/sh+7,675,160$1,535,032→ 8,223,695 total
Footnotes (3)
- [F1]Not applicable.
- [F2]The securities listed in Table I and II are securities owned directly by Dr. Salkind and his wife and by a family trust.
- [F3]Includes dividend shares issued upon conversion.